Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 243.61 USD -0.27% Market Closed
Market Cap: 35.8B USD
Have any thoughts about
Resmed Inc?
Write Note

Resmed Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Resmed Inc
Cash from Financing Activities Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Cash from Financing Activities
-$1.1B
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
-14%
Becton Dickinson and Co
NYSE:BDX
Cash from Financing Activities
$966m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Cash from Financing Activities
$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Cash from Financing Activities
$983m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Cash from Financing Activities
-$6.4B
CAGR 3-Years
-13%
CAGR 5-Years
2%
CAGR 10-Years
-5%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Financing Activities
$70m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Resmed Inc's Cash from Financing Activities?
Cash from Financing Activities
-1.1B USD

Based on the financial report for Sep 30, 2024, Resmed Inc's Cash from Financing Activities amounts to -1.1B USD.

What is Resmed Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-14%

The average annual Cash from Financing Activities growth rates for Resmed Inc have been -31% over the past three years , and -14% over the past ten years .

Back to Top